Dev48
Language
  • About
  • Services
  • Industries
  • Technologies
  • Articles
  • Contacts
Book a call
    Home/Articles/Getinge appoints stacy beske as president acute care therapies
Dev48
info@dev48.org+375 29 320-40-96WhatsApp@isky_by

© 2026 · All rights reserved.

Getinge appoints Stacy Beske as President Acute Care Therapies

Фото: Maryseh (Pixabay) — https://pixabay.com/photos/hand-massage-massage-treatment-7440712/

Source: Getinge•November 14, 2026 at 03:03 PM

Getinge appoints Stacy Beske as President Acute Care Therapies

Getinge has appointed Stacy Beske as President Acute Care Therapies and member of the Executive Team, reporting to Mattias Perjos, President & CEO. She will assume the position on December 1, 2026.

Press release Gothenburg, Sweden, on November 9, 2026

Regulatory | 11/9/2026

Getinge has appointed Stacy Beske as President Acute Care Therapies and member of the Executive Team, reporting to Mattias Perjos, President & CEO. She will assume the position on December 1, 2026.

Beske joins Getinge from Philips where she most recently served as Senior Vice President, Business Unit Leader for Image Guided Therapy Devices. She holds a Ph.D. in Cardiovascular Physiology, has an extensive research background, and brings 20+ years of leadership experience across medtech, including image-guided therapy, diabetes, electrophysiology, diagnostics, and cardiovascular care.

“Stacy has a strong track record of leading complex businesses and transformations, building high-performing teams and turning strategy into results,” says Mattias Perjos, President & CEO at Getinge. “This experience will be valuable as we deliver on our commitment to continue strengthening Acute Care Therapies by building on the progress made in recent years.”

“I am very excited to join Getinge and to be leading Acute Care Therapies,” says Beske. “The business has a strong portfolio and a crucial role in helping healthcare professionals improve outcomes for patients. I look forward to working with my new colleagues across the globe to build on that foundation, accelerate innovation and continue advancing the business.”

Stacy Beske will be based at Getinge’s office in Wayne, New Jersey. She succeeds Elin Frostehav, who will leave Getinge to take on an external opportunity after supporting a smooth transition.

Media contact:

Caroline Örmgård, Head of Media Relations Phone: +46 (0)10 335 0041 Email: caroline.ormgard@getinge.com

About Getinge With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries.

You are now leaving Getinge.com. You may access content that is not managed by the Getinge team, in which case Getinge can not be held responsible for the content.

← All articles

What this article says

More in HealthTech & MedTech

All →
Getinge establishes Sustainable Financing Framework
Getinge

Getinge establishes Sustainable Financing Framework

A framework for AI evaluation in healthcare
Athenahealth

A framework for AI evaluation in healthcare

Powering Faster Multi-Agency Data Exchange | Veeva
Veeva Systems

Powering Faster Multi-Agency Data Exchange | Veeva

Building the Foundation for Agentic Safety | Veeva
Veeva Systems

Building the Foundation for Agentic Safety | Veeva

How athenaOne® unifies AI across the clinical workflow
Athenahealth

How athenaOne® unifies AI across the clinical workflow

From months to days: how nanopore sequencing is transforming genomic investigations at VCGS
Oxford Nanopore

From months to days: how nanopore sequencing is transforming genomic investigations at VCGS

More from Getinge

Getinge establishes Sustainable Financing Framework
Getinge

Getinge establishes Sustainable Financing Framework

Getinge Interim Report July-September 2026: Increased profitability, strong cash flow and higher customer satisfaction
Getinge

Getinge Interim Report July-September 2026: Increased profitability, strong cash flow and higher customer satisfaction

Nomination Committee appointed ahead of Getinge’s Annual General Meeting 2027
Getinge

Nomination Committee appointed ahead of Getinge’s Annual General Meeting 2027

Getinge brings its smallest Edi catheter to the U.S. market following FDA clearance
Getinge

Getinge brings its smallest Edi catheter to the U.S. market following FDA clearance

Getinge invites fund managers, analysts, and media to Q3 Report 2026 conference call
Getinge

Getinge invites fund managers, analysts, and media to Q3 Report 2026 conference call

Getinge announces departure of Eric Honroth, President Life Science
Getinge

Getinge announces departure of Eric Honroth, President Life Science